Scopia Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elastic
ESTC
|
+$23.8M |
| 2 |
Dollar Tree
DLTR
|
+$20.9M |
| 3 |
Driven Brands
DRVN
|
+$16.2M |
| 4 |
JFrog
FROG
|
+$14M |
| 5 |
Chemours
CC
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Indivior Pharmaceuticals
INDV
|
+$54.1M |
| 2 |
Harmonic Inc
HLIT
|
+$45.4M |
| 3 |
Fortrea Holdings
FTRE
|
+$34.3M |
| 4 |
Mercury Systems
MRCY
|
+$22.1M |
| 5 |
SGI
Somnigroup International
SGI
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 37.99% |
| 2 | Technology | 28.52% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Materials | 8.76% |
| 5 | Consumer Staples | 5.77% |
Similar funds
Scopia Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Scopia Capital Management held 41 positions worth $485M, down 28% from $675M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Scopia Capital Management withdrew a net $205M in Q3 2024, closing 7 positions and reducing 15 holdings. Its most notable exit was Fortrea Holdings, an estimated $34.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Scopia Capital Management opened a new position in Elastic worth $18.5M.
- Scopia Capital Management's largest Q3 2024 buy was Elastic: 241,268 shares worth $18.5M.
- Scopia Capital Management added most to Corteva in Q3 2024, an estimated $7.93M increase.
- Scopia Capital Management's biggest Q3 2024 reduction was Indivior Pharmaceuticals, cutting an estimated $54.1M.
- Scopia Capital Management fully exited Fortrea Holdings in Q3 2024, selling an estimated $34.3M.
- Scopia Capital Management's ten largest holdings make up 50% of its $485M portfolio in Q3 2024.
- Scopia Capital Management opened 8 new positions and closed 7 in Q3 2024.
- Scopia Capital Management's portfolio value fell 28% quarter-over-quarter to $485M.
Based on Scopia Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.